Healthcare provider profile · identity verified

Cassandra Stephens, MD

Family Practice · CAMPBELLSVILLE, KY · NPI 1710983564

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	266	63
Lisinopril	Lisinopril	238	61
Atorvastatin Calcium	Atorvastatin Calcium	232	61
Amlodipine Besylate	Amlodipine Besylate	218	55
Gabapentin	Gabapentin	210	35
Omeprazole	Omeprazole	155	42
Losartan Potassium	Losartan Potassium	153	43
Pantoprazole Sodium	Pantoprazole Sodium	134	34
Metoprolol Tartrate	Metoprolol Tartrate	121	31
Hydrochlorothiazide	Hydrochlorothiazide	120	39
Metformin Hcl	Metformin Hcl	106	26
Glimepiride	Glimepiride	98	20
Furosemide	Furosemide	89	26
Metoprolol Succinate	Metoprolol Succinate	87	18
Meloxicam	Meloxicam	82	21
Atenolol	Atenolol	79	18
Potassium Chloride	Potassium Chloride	74	18
Duloxetine Hcl	Duloxetine Hcl	72	15
Fluconazole	Fluconazole	69	38
Tamsulosin Hcl	Tamsulosin Hcl	69	16
Citalopram Hbr	Citalopram Hydrobromide	68	21
Allopurinol	Allopurinol	66	16
Eliquis	Apixaban	64	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	13
Celecoxib	Celecoxib	61	19
Diazepam	Diazepam	61	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	59	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	11
Zolpidem Tartrate	Zolpidem Tartrate	56	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	54	15
Carvedilol	Carvedilol	53	13
Montelukast Sodium	Montelukast Sodium	52	suppressed
Pravastatin Sodium	Pravastatin Sodium	52	14
Clopidogrel	Clopidogrel Bisulfate	51	13
Simvastatin	Simvastatin	51	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	12
Bumetanide	Bumetanide	48	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	48	12
Spironolactone	Spironolactone	48	12
Finasteride	Finasteride	46	suppressed
Famotidine	Famotidine	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	suppressed
Mirtazapine	Mirtazapine	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Clonazepam	Clonazepam	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Prednisone	Prednisone	43	30
Lorazepam	Lorazepam	42	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	24
Cefdinir	Cefdinir	38	30
Estradiol	Estradiol	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Trazodone Hcl	Trazodone Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Oxycontin	Oxycodone Hcl	33	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Naproxen	Naproxen	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Ozempic	Semaglutide	30	suppressed
Glipizide	Glipizide	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Pregabalin	Pregabalin	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Azithromycin	Azithromycin	17	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Nystatin	Nystatin	16	suppressed
Temazepam	Temazepam	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Methylprednisolone	Methylprednisolone	15	13
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error